(Q73504193)
Statements
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response (English)
R M Bukowski
T Olencki
Q Wang
D Peereboom
G T Budd
P Elson
K Sandstrom
L Tuason
P Rayman
R Tubbs
D McLain
E Klein
A Novick